Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
3M Reaches $10.3 Billion Settlement
3M Co. reached a $10.3 billion agreement to settle lawsuits that claimed toxic chemicals had contaminated drinking water across the country.
Load More